Article
A multinational trial finds a statistically significant number of patients with Behçet's syndrome showed a greater reduction in the number of oral ulcers with apremilast compared with placebo.
All News
Article
Recent studies have quantified the gender gap among speakers at academic conferences. The largest study of 181 medical conferences held in North America over one decade found an increase in the proportion of female speakers from 25 to 34% over time, and that the underrepresentation of women was more marked at surgical compared to medical conferences.
Dr. John Cush
Tweet
Metanalysis shows that although MTX may blunt some vaccine responses (eg Pneumococcal), the use of MTX, TNF inhibitors and other biologics should not deter vaccination as most vaccine responses are preserved despite therapy. https://t.co/KINrQMIQkt
Dr. John Cush
Tweet
We are all going to get sick, the what and why is often unknown . This may be the hardest thing you'll ever do through. How you go through it will define you and deliver you..
Dr. John Cush
Tweet
(the Fonz says) Tenacity and gratitude are 2 words to live by. - Henry Winkler
Leonard Calabrese
Tweet
Me and @AdamJBrownMD of Rheumination game in the studio to do @VindicoMedEd curbside consults on GCA! Sometimes the Dx is NOT so easy!!!Stay tuned to us and @HealioRheum @AWIRGROUP @RheumNow @VasculitisFound @ramos_casals https://t.co/nnMC9r5LsH
Dr. Paul Sufka
Tweet
Looks like the latest ACR on Air podcast is up — episode 5 — recorded during #ACR19 with host @hausmannMD and @DrBhana and myself as guests. We discuss a couple of our favorite abstracts from the meeting. @ACRheum https://t.co/WHNiHuhenZ
Dr. John Cush
Tweet
Very cool minilecture on how to read RCTs! https://t.co/jQUawxcEr1
Rheumatology Network
Tweet
Gout Attacks Intensify with Heart Failure #cardiovascular https://t.co/LxCw8sCv5P https://t.co/ZukMrWuaeF
Jeff Sparks
Tweet
Our new review article is online detailing airway inflammation and RA pathogens is - Obstructive lung diseases and risk of rheumatoid arthritis https://t.co/Nmj9Uf6isl https://t.co/ByWVI0fYwa
Dr. John Cush
Tweet
Guselkumab, anti-IL23 in PsA
Ph3 DISCOVER-1 trial in bio-naive or 30% prior TNFi = Effective at Wk 24
Safety same as with psoriasis trials. No Tb signal, No IBD signal.
#ACR19 Abst0807 @_connectedcare https://t.co/d7hrn8VQO8
Dr. John Cush
Tweet
Phase 2b Bimekizumab study results in PsA shows neutralizing IL 17F and IL 17A may be a new target for LDA/treatment. https://t.co/45Vahy36g7 #ACR19 @uptoTate
abs#2881
Dr. John Cush
Tweet
I didn’t realize how fast Pegloticase works. Assuming the urate burden of a gout patient, Pegloticase can degrade all the urate in the body over 5-40 days!
#ACR19 3S050 Lipsky @_connectedcare
Eric Ruderman
Tweet
Panel Presentation: What’s New in Psoriatic Arthritis. So honored to join my colleagues Alexis Ogdie, Jose Scher, and Jessie Walsh to discuss the latest therapies in PsA https://t.co/Hl5r5xVygK via @YouTube #Rheumnow #ACR2019 #ACR19 #PsA
Dr. John Cush
Tweet
Crossreactivity events between allopurinol rashes and febuxostat are very low https://t.co/jVVQhtB0CK
Dr. John Cush
Tweet
New package labeling says febuxostat should only be considered after allopurinol has been tried or is contraindicated. https://t.co/Sk2MhEiOhv
Dr. John Cush
Tweet
PANLAR KOL recommendations for MSUS in gout clinic. Abs #301 https://t.co/uziDzNM0VX #ACR19 @uptoTate
@RheumNow
John M. Davis, III
Tweet
Great piece by @jeffsparks and team on the role of airway inflammation and the pathogenesis of RA. #rheumatoidarthritis #rheum https://t.co/E2euIPuRab
Dr. Paul Sufka
Tweet
Abstr# 1161: Gadolinium-enhanced MRI of the shoulders showing inflammatory changes in pts with PMR. Helpful to diagnose and detect recurrence. #ACR19 #ACRBest @RheumNow https://t.co/FMvLYtIr3P
Dr. John Cush
Tweet
Abstract L06 shows the efficacy of Emapalumab, an IFN-γ mAb, when given to 9 systemic JIA pts who developed macrophage activation syndrome. Highly effective showing ability to lower steroid use #ACR19
#ACRBest https://t.co/OXTwpkyhlq
